Iovance Biotherapeutics, Inc. (IOVA) intrinsic value

Price $14.22 on 2026-10-05.

MethodValueMargin of safety
DCF – bear case-$27.80
DCF – base case-$49.76-450.1%
DCF – bull case-$80.46
Graham Number——

WACC 9.1%, revenue growth 65.7%, FCF margin -57.8%, EPS -$0.69, book value per share $1.63. 2 valuation runs recorded.

Community analyses of IOVA

More valuations

Run your own DCF · How accurate are these valuations?